Page last updated: 2024-10-28

hydralazine and Kidney Neoplasms

hydralazine has been researched along with Kidney Neoplasms in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research Excerpts

ExcerptRelevanceReference
"Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis."7.72P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003)
"Renal cell carcinoma and hydralazine drug therapy has each been reported as rare associations with pauci-immune renal vasculitis."3.72P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. ( Jeffrey, RF; Leeds, J; Norris, JH, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Norris, JH1
Leeds, J1
Jeffrey, RF1
Knowles, HJ1
Tian, YM1
Mole, DR1
Harris, AL1
Tucker, RM1
Hunt, JC1

Reviews

1 review available for hydralazine and Kidney Neoplasms

ArticleYear
Recent advances in the medical and surgical treatment of hypertension.
    The Medical clinics of North America, 1968, Volume: 52, Issue:5

    Topics: Adrenocortical Hyperfunction; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Ethacryni

1968

Other Studies

2 other studies available for hydralazine and Kidney Neoplasms

ArticleYear
P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy.
    Renal failure, 2003, Volume: 25, Issue:2

    Topics: Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Carcinoma, Renal Cell; Humans; Hydr

2003
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Circulation research, 2004, Jul-23, Volume: 95, Issue:2

    Topics: Adrenomedullin; Angiogenesis Inducing Agents; Animals; Breast Neoplasms; Carcinoma; Carcinoma, Renal

2004